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1. Introduction 
1.1 Pathophysiology of type I diabetes mellitus: Role of pro-inflammatory cytokines 
Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterised by the destruction 
of insulin-producing ┚-cells in the pancreatic islets of Langerhans (Fig.1), which is mediated 
by autoreactive T cells, macrophages and pro-inflammatory cytokines (Fig.2). This leads to 
an inability to produce sufficient insulin resulting in elevated blood glucose levels and 
pathological effects (Eizirik & Mandrup-Poulsen, 2001). 
T1DM is believed to be initiated by physiological -cell death or islet injury triggering the 
homing of macrophages and dendritic cells that in turn launch an inflammatory reaction. 
The infiltrating macrophages secrete pro-inflammatory cytokines, namely interleukin-1┚ 
(IL-1 and tumour necrosis factor  (TNF as well as various chemokines that attract 
immune cells such as dendritic cells, macrophages and T lymphocytes. T cells recognising -
cell-specific antigens become activated, infiltrate the inflamed islets and attack the -cells 
(Baekkeskov et al., 1990, Elias et al., 1995, Lieberman et al., 2003, Nakayama et al., 2005). In a 
normally functioning immune system, T cells with a high affinity for self-antigens are 
eliminated during their differentiation resulting in immune ‘tolerance’. Autoreactive cells 
that have escaped these mechanisms are subject to ‘peripheral immune regulation’ that 
blocks their activation and clonal expansion, preventing development of an autoimmune 
disease (Mathis & Benoist, 2004). For reasons we do not fully understand, these immune 
regulatory mechanisms either fail to launch, or are ineffective in stopping the immune 
attack against the -cells in T1DM, and a positive feedback cycle is established (Mathis & 
Benoist, 2004). This forward-feeding process of T cell- and cytokine-mediated -cell killing 
can be ongoing for years progressively destroying the -cells. When over 80 % of the -cells 
are deleted by this continuous T lymphocyte and inflammatory cytokine-driven attack the 
insulin secretory capacity falls below a certain threshold and the disease manifests itself.   
Activated T cells induce death of a target cell by (1) secreting perforin and granzymes, (2) 
releasing pro-inflammatory cytokines including interferon-┛ (IFN┛) and TNF┙ or (3) 
activation of Fas receptors on the surface of target cells. All these factors have also been 
described to contribute to ┚-cell killing in T1DM (Kägi et al., 1997, D. Liu et al., 2000, 








Fig. 1. ┚-cell islets in the pancreas of (A) pre-diabetic and (B) diabetic NOD mice. The yellow 
arrows indicate the islets in the haematoxylin-eosin stained tissue section (original 
magnification 200X).  
cytokines IL-1┚, TNF┙ and IFN┛ that are secreted by macrophages and T cells have a 
broader role in the development of T1DM than previously thought. They are the main 
inducers of ┚-cell stress responsible for significant levels of -cell death in both rodent 
(Iwahashi et al., 1996, Rabinovitch et al., 1994) and human (Delaney et al., 1997) 
experimental models of T1DM. 
Underlining the importance of the cytokines, it has been shown that neutralisation of the 
pro-inflammatory cytokines by antibodies and/or soluble cytokine receptors against IL-1, 
IFN IL-6 and TNF can inhibit the development of T1DM in NOD mice or BB rats 
(Mandrup-Poulsen, 1996). Transgenic mice expressing IFN in -cells develop severe 
insulitis (pre-diabetes) and destruction of -cells. Treatment of these mice with anti-
IFNantibody prevents the development of T1DM. IFN-deficient mice as well as mice 
injected with neutralising anti-IFN receptor antibodies were resistant to development of 
experimentally-induced T1DM (Cailleau et al., 1997, Seewaldt et al., 2000, B. Wang et al., 
1997). Similar to IFN, genetic or pharmacological abrogation of IL-1┚ action also reduces 
disease development in animal models of T1DM (Mandrup-Poulsen et al., 2010). 
Although many factors contribute to ┚–cell destruction during T1DM, in this book chapter 
we review current knowledge regarding the role of cytokines mediating ┚–cell stress and 
death in T1DM. 
1.2 Signal transduction of pro-inflammatory cytokines in -cells 
IL-1┚, IFN┛ and TNF┙ exert a variety of effects on -cells. They sensitise -cells to apoptosis 
by increasing the expression of pro-apoptotic proteins, such as the Fas receptor (Stassi et al., 
1997). They drive and stabilise the autoimmune response by triggering the secretion of 
chemokines (e.g. CXCL9 and CXCL10) by -cells (Frigerio et al., 2002), which results in 








Fig. 2. Cytokine-induced ┚-cell death. Initial ┚-cell death caused by injury, infection or 
physiologically during development can activate an autoimmune response that leads to 
activation and infiltration of cytokine-secreting macrophages, dendritic cells (DC) and T 
cells (TC). Pro-inflammatory cytokines IL-1┚, TNF┙ and IFN┛ secreted by macrophages and 
TCs cause ┚-cell stress and death and secretion of chemokines that further stimulate 
autoimmune cell infiltration. 
cause stress in -cells which eventually activates the cell’s death machinery. The signal 
transduction pathways activated by these pro-inflammatory cytokines leading to chemokine 
secretion, ┚-cell stress and death are detailed below (also see Fig. 3). 
It is very important to note that any of the above pro-inflammatory cytokines alone has 
limited effects in terms of cell stress or death, on -cells. However, combinations of IL-
1┚/IFN or TNF/IFN have very strong, synergistic effects that trigger serious levels of 
stress culminating in cell death. 
1.2.1 IL-1く signalling 
The main mediator of IL-1┚ signalling is the transcription factor nuclear factor kappa B (NF-
B) (Flodström et al., 1996, Kwon et al., 1995). The pathway by which IL-1┚ activates NF-B 
has been delineated in a number of cell types and experimental models (Fig.3). It is thought 
that the same mechanisms are involved in pancreatic -cells. IL-1┚, secreted by activated 
macrophages and T cells, binds to the IL-1 receptor 1 (IL-1R1) on the surface of target cells. 
IL-1R1 then recruits IL-1 receptor accessory protein (IL-1RAcP) (Dinarello, 1997). This 
allows binding of the adaptor protein myeloid differentiation factor 88 (MyD88) and 
recruitment of IL-1R1 activated kinase 1 (IRAK1) and/or IRAK2 (Burns et al., 1998, Muzio et 
al., 1997, Wesche et al., 1997). IRAK proteins are in  complex with a protein named Tollip 
prior to recruitment to the receptor (Burns et al., 2000). Tollip associates with IL-1RacP when 








Fig. 3. Cytokine-signalling in pancreatic ┚-cells. IL-1┚, TNF┙ and IFN┛ activate receptors on 
the surface of ┚-cells inducing a signalling cascade leading to the activation of transcription 
factors STAT1 and NF-κB that control numerous genes involved in ┚-cell function, 
inflammation, stress responses and apoptosis. 
factor-6 (TRAF6) is recruited to IRAK1 and IRAK2 (Muzio et al., 1997, Yamin & Miller, 1997) 
leading to the activation of inhibitor of NF-κB (IκB) kinase (IKK) via NF-κB inducing kinase 
(NIK). IKK then phosphorylates IκB which triggers its degradation and the release of the 
transcription factor NF-κB from the inhibitory interaction.  
In addition, phosphatidyl inositol-3 kinase (PI3K) is recruited to the activated IL1-R1 
complex where it becomes activated (Reddy et al., 1997, Reddy et al., 2004). PI3K activity is 
required, but not sufficient for NF-κB activation (Reddy et al., 1997).  
NF-κB can regulate the transcription of numerous target genes (for review see (Pahl, 1999)). 
The target genes include cytokines (e.g. IL-1┚, TNF┙, IFN┛), chemokines, immunoreceptors, 
proteins involved in antigen presentation, cell adhesion molecules, stress response genes, 
regulators of apoptosis (both pro- and anti-apoptotic), growth factors and other transcription 
factors. The effects of NF-κB signalling are highly cell type-specific. In most cell types the net 
effect of NF-κB activation is to promote cell survival. In contrast, in ┚-cells NF-κB activation 
has a pro-apoptotic effect (Eldor et al., 2006, Ortis et al., 2008). These studies demonstrate that 
inhibition of NF-κB protects rodent pancreatic ┚-cells from the damaging effects of cytokine-
exposure in vitro and prevents streptozocin-induced diabetes in vivo.   
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A large number of NF-κB target genes were identified using DNA microarray technology in 
cytokine-treated primary rat ┚-cells (Cardozo et al., 2001a). Cytokines induced NF-κB-
dependent up-regulation of genes involved in stress responses (including CHOP, C/EBP┚ 
and ├, Hsp27 and MnSOD), immune responses (e.g. MHC-II-associated invariant chain ┛ 
and MHC-I) and down-regulation of genes involved in ┚-cell function (glucose transporter-2 
(Glut-2)), insulin production (Isl-1), insulin processing (PC-1), insulin release (PLD-1, 
CCKA-receptor) and Ca2+ homeostasis (SERCA2, IP 3-kinase) (Cardozo et al., 2001a).  
Inducible nitric oxide synthase (iNOS) is strongly induced and is the best characterised NF-
κB target in both rat ┚-cells (Cardozo et al., 2001a, Kutlu et al., 2003) and human pancreatic 
islets (Flodström et al., 1996). Induction of iNOS increases nitric oxide (NO) production in ┚-
cells, resulting in the generation of reactive oxygen species (ROS) and oxidative stress. The 
cellular stress triggered by NO in rodent and human cells will be discussed later in this 
chapter (under section 2.2).  
In addition to NF-κB, IL-1┚ signalling also activates the mitogen activated protein kinase 
(MAPK) extracellular signal-regulated kinase (ERK) 1/2 and induces suppressor of cytokine 
signalling-3 (SOCS-3) (Emanuelli et al., 2004). Signal transduction pathways induced by 
MAPKs and SOCS-3 are interlinked with the NF-κB-regulated pathways; MAPK activation 
potentiates IL-1┚-dependent NF-κB activation and subsequent iNOS induction, and 
(ERK)1/2 activation was shown to contribute to cytokine-induced apoptosis in rat 
pancreatic -cells (Pavlovic et al., 2000). While MAPKs positively affect NF-κB signalling 
and enhance ┚-cell death, SOCS-3 has a negative effect. SOCS-3 belongs to a family of 
proteins that provide a negative feedback for cytokine-induced signalling. It was also 
identified as an inhibitor of insulin signalling (Emanuelli et al., 2000) as SOCS-3 can bind to 
the insulin receptor and block its insulin-induced autophosphorylation and activation 
(Emanuelli et al., 2004). SOCS-3 inhibits IL-1┚ signalling upstream and thus negatively 
regulates nearly all effects of IL-1┚. SOCS-3 suppresses the expression of several IL-1┚-
induced pro-apoptotic genes, many of them known to be NF-κB-dependent (Karlsen et al., 
2004) and protects rat ┚-cells from IL-1┚- and TNF┙-induced cell death (Bruun et al., 2009). 
As mentioned above, over 200 genes have been identified to be NF-κB-regulated in ┚-cells 
treated with pro-inflammatory cytokines. However, which of these genes are targets of IL-
1┚ signalling, or to what extent their expression is regulated by IL-1┚ alone is currently 
unknown. Determining the individual targets of the cytokines would lead to a better 
understanding of how the cytokines synergise to cause ┚-cell stress and death. 
1.2.2 TNFα signalling 
TNF┙ was also shown to lead to activation of NF-κB in pancreatic ┚-cells (Ortis et al., 2006). 
TNF┙ binds to and activates the TNF receptor (TNFR1), which is present on the surface of ┚-
cells (Kägi et al., 1999). TNF┙ binding to TNFR1 leads to the latter’s trimerisation and 
activation (Fig. 3). Upon activation, the cytosolic death domain of TNFR1 recruits TNF 
receptor-associated death domain (TRADD) (Hsu et al., 1995), TRAF2 (Hsu et al., 1996b) and 
the death domain kinase receptor interacting protein (RIP) (Hsu et al., 1996a). TRAF2, in 
turn, recruits IκB kinase (IKK) and induces its activation in a RIP-dependent manner via 
activation of an IKK kinase (e.g. NIK) (Devin et al., 2000). Activated IKK phosphorylates IκB 
proteins leading to their proteasomal degradation and release of NF-κB. The activation of 
NF-κB by both TNF┙ and IL-1┚ has a pro-apoptotic effect in rat pancreatic ┚-cells (Ortis et 
al., 2008). This effect was more pronounced in response to IL-1┚ than TNF┙. 
www.intechopen.com
 
Type 1 Diabetes – Complications, Pathogenesis, and Alternative Treatments 
 
218 
TNF┙ signalling can lead to RIP-dependent activation of three MAPKs (c-Jun N-terminal 
kinase JNK, p38 and ERK) in a cell type-specific manner (Devin et al., 2003). In rat pancreatic 
┚-cells, TNF┙ treatment induced activation of JNK and p38 which has been suggested to 
contribute to an inhibitory effect of TNF┙ on glucose-stimulated insulin secretion (H.-E. Kim 
et al., 2008) and hence ┚-cell dysfunction in response to TNF┙. 
1.2.3 IFNけ signalling 
IFN┛ is a homodimeric cytokine. It binds to two IFN┛ receptor ┙ (IFN┛R┙) chains (Fig. 3). A 
third unit of IFN┛R┙ and two molecules of IFN┛ receptor ┚ (IFN┛R┚, also termed accessory 
factor 1, AF-1) bind to the IFN┛R┙ (Thiel et al., 2000). This leads to the activation and 
transphosphorylation of Janus tyrosine kinase 1 and 2 (JAK1 and JAK2) which are 
associated with IFN┛R┙ and IFN┛R┚, respectively, and are brought together upon receptor 
oligomerisation (Igarashi et al., 1994, Kotenko et al., 1995). JAK1 and JAK2 phosphorylate 
IFN┛R leading to the recruitment of two molecules of the transcription factor, signal 
transducer and activator of transcription-1 (STAT-1). After phosphorylation and activation 
by JAK2, STAT-1 homodimerises and translocates to the nucleus where it stimulates the 
expression of target genes (Takeda & Akira, 2000).  Islet cells isolated from STAT-1-/- non-
obese diabetic (NOD) mice were resistant to apoptosis induced by combined treatment with 
IFN┛ and TNF┙ or IFN┛ and IL-1┚ (S. Kim et al., 2007). In support of this, blockade of STAT-
1 protected against diabetes induced by injection of multiple low doses of streptozotocin in 
mice (Callewaert et al., 2007, C.A. Gysemans et al., 2005). A recent gene expression analysis 
showed that nearly two thousand genes are regulated by STAT-1 in response to cytokine 
exposure (IL-1┚ and IFN┛) in ┚-cells (Moore et al., 2011). STAT-1 was found to regulate the 
IL-1┚/IFN┛-mediated induction of chemokines, including CXCL9, CXCL10, CXCL11 and 
CCL20 (Moore et al., 2011) and islets from STAT-1-/- mice have decreased production of 
CXCL10 upon cytokine exposure both in vitro and in vivo (C.A. Gysemans et al., 2005). 
STAT-1 also down-regulates several genes specific to ┚-cell functions, such as insulin, 
glucokinase, Glut2, prohormone convertases, as well as many transcription factors involved 
in the differentiation and maintenance of ┚-cell phenotype (e.g. Pdx1, MafA, Nkx2.2) (Moore 
et al., 2011, Perez-Arana et al., 2010). 
Finally, STAT-1 is an important regulator of genes mediating intracellular stress and 
apoptotic pathways. Several apoptosis-related genes such as Puma, CHOP, Bax, Bid, 
caspase-3, -4, -7, DP5/Hrk and endoplasmic reticulum stress-transducing genes (XBP1, 
ATF4) are regulated by STAT-1 (Eizirik & Darville, 2001, Moore et al., 2011, Anastasis 
Stephanou et al., 2000). IFN┛ has been found to profoundly accelerate IL-1┚-mediated iNOS 
induction and thus cause oxidative stress. We have demonstrated that treatment of a rat 
insulinoma cell line (RIN-r) with a combination of IL-1┚ and IFN┛ induces the 
mitochondrial apoptotic pathway in an iNOS-dependent manner (Holohan et al., 2008). This 
is in line with reports from other groups (Gurzov et al., 2009). 
The inflammatory effects of IFN┛ are controlled by negative feedback regulation, exerted by 
interferon regulated factor-1 (IRF-1) (Moore et al., 2011) and SOCS-1 and -3 (Alexander, 
2002). IRF-1 is likely to exert its STAT-1 regulatory role by up-regulation of SOCS-1 (Moore 
et al., 2011). IRF-1 expression reduces chemokine expression in ┚-cells and resulting T cell 
infiltration in Langerhans islets (C. Gysemans et al., 2008, Moore et al., 2011), however the 
effect of IRF-1 on STAT-1-mediated ┚-cell de-differentiation (loss of ┚-cell function) and -
cell stress is minor (Moore et al., 2011). In line with this, transgenic expression of SOCS-1 in 
┚-cells reduced diabetes development in non-obese diabetic (NOD) mice (Flodström-
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Tullberg et al., 2003) and protected ┚-cells against infiltrating autoreactive T cells (Chong et 
al., 2004). In summary, the effect of IFN┛ in ┚-cells is primarily mediated by STAT-1 through 
which IFN┛ controls key processes culminating in loss of ┚-cell function, stress and finally 
death. IFN┛ regulates a number of genes that increase the sensitivity of ┚-cells to apoptotic 
stimuli and intracellular stress.  
2. Cytokine-induced く-cell death 
2.1 Mechanisms of cytokine-induced く-cell death 
During the development of T1DM, there are two waves of ┚-cell death. It is believed that ┚-
cell death is the initial trigger for the autoimmune attack. While autoimmune attack was 
thought to be initiated by cytolytic activity or immune-stimulation of viruses (Jun & Yoon, 
2003), it is also possible that physiological -cell death might be a trigger. Instead of an 
exogenous impact, or environmental effect, induction of diabetes might be initiated during 
physiological tissue remodelling of the pancreas peaking at age 2-3 weeks in rodents. At this 
time, an increased level of ┚-cell death occurs in the islets and might be the primary trigger 
of the autoimmune attack (Turley et al., 2003). Programmed cell death associated with 
normal tissue remodelling does not induce inflammation. However, if the dead cells are not 
removed promptly by phagocytosis they can disintegrate and release cellular contents in a 
manner similar to pathological tissue damage which can trigger inflammation. In fact, 
accumulation of dead cells has been noticed in NOD mice and similarly, disintegrating, so 
called secondary necrotic cells were sufficient to induce inflammation, macrophage 
infiltration and pre-diabetic insulitis in NOD mice (H.S. Kim et al., 2007). 
The second wave of ┚-cell death is driven by the autoimmune reaction. This is an ongoing 
process gradually killing the ┚-cells and culminating in the disease phenotype. The 
mechanism of ┚-cell death induced by the autoreactive leukocytes has been extensively 
examined with consensus that the major form of ┚-cell death is apoptosis, however, under 
certain conditions and especially in rodent experimental models of T1DM, necrotic ┚-cell 
death can also contribute to ┚-cell loss. 
Apoptosis is a physiological form of cell death involved in the elimination of cells that have 
served their function, are no longer needed or are damaged. It is an active, highly ordered 
and rapid process characterised by the detachment of the dying cell from its neighbours, cell 
shrinkage, condensation of chromatin, fragmentation of the nucleus and finally 
fragmentation of the cell into membrane bound particles, called apoptotic bodies which are 
engulfed by neighbouring cells or professional phagocytic cells (Samali et al., 1996). By this 
means, cells are eliminated without leakage of otherwise inflammatory cellular material.  
The morphological changes typical of apoptosis are orchestrated by the caspase family of 
proteases (Samali et al., 1999). Caspases are activated by two distinct mechanisms. The 
extrinsic pathway is triggered by an extracellular pro-apoptotic stimulus, usually a cytokine 
that belongs to the death ligand subfamily of the TNF superfamily. Upon engagement of the 
death ligand with its cognate death receptor on the cell surface of the target cell, the 
receptors trimerise and induce the formation of a protein complex, called the death-inducing 
signalling complex (DISC). The DISC is an activation platform for caspases-8 and/or -10 
(Peter & Krammer, 2003). Once these initiator caspases are activated they activate 
downstream effector caspases, which leads to a burst of caspase activity and subsequent 
proteolysis that dismantles the cells.  
The second, so called intrinsic pathway is initiated at the level of mitochondria. Upon 
intracellular stress these organelles release cytochrome c that associates with the adaptor 
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protein APAF-1 to build a multimeric cytoplasmic protein complex termed the apoptosome, 
which functions  to activate another initiator caspase, caspase-9 (Riedl & Salvesen, 2007). 
Mitochondrial release of cytochrome c, and thus activation of the intrinsic apoptosis 
pathway, is controlled by members of the Bcl-2 family of proteins (see section 2.3). Once 
cytochrome c is released and caspase-9 is activated, the same caspase cascade is triggered as 
during the extrinsic apoptotic pathway that leads to the final demise of the cell. 
Interestingly, TNF┙ was shown to induce expression of an endogenous caspase inhibitor in 
-cells that prevents apoptosis, the X-linked inhibitor of apoptosis protein (XIAP). This NF-
kB-mediated induction of XIAP is inhibited by IFN┛ signalling, providing a mechanism for 
synergistic cytoxicity of TNF┙ and IFN┛ in ┚-cells (H.S. Kim et al., 2005). 
Apoptosis is distinguished from necrosis, a pathological, mostly uncontrolled mode of cell 
death. During necrosis cells swell, their membranes disintegrate and their content is 
released, inducing inflammation. Recently, an active mode of necrosis, termed necroptosis, 
has been described that can be induced upon activation of TNFR1 when caspase-8 activation 
is blocked (Vandenabeele et al., 2010). A possible role of necroptosis in initiation of diabetes 
seems worthy of further investigation in light of the known involvement of TNFR1 
signalling in diabetes and of a recent study that provided evidence of necrotic ┚-cell death 
playing a role in initiating autoimmune-type diabetes (Steer et al., 2006). 
2.2 The role of nitric oxide in cytokine-mediated く-cell loss 
It is thought that cytokine-induced ┚-cell stress and death is partly caused by intracellular 
production of ROS and NO. NO is a gaseous hydrophobic signalling molecule that readily 
diffuses through membranes and plays an essential role in various neurological, 
immunological and cardiovascular processes. The biosynthesis of NO is catalysed by nitric 
oxide synthases (NOS). In ┚-cells IL-1┚ signals up-regulation of iNOS and subsequent 
generation of NO. The main physiological effect of NO is mediated via the direct activation 
of guanylyl cyclase by NO leading to production of cyclic GMP (cGMP) and activation of 
cGMP-dependent signal transduction pathways. However, if present for a prolonged period 
or in high quantities, NO can nitrosylate specific cysteine residues of various proteins (S-
nitrosylation) forming nitrosothiols and thereby affect the protein’s activity, stability and 
localisation (Hess et al., 2005). In most cases this leads to rapid degradation of the 
nitrosylated proteins but a small subgroup of proteins have been shown to gain stability 
after nitrosylation (Paige et al., 2008). NO can have anti-apoptotic and cytoprotective effects 
in some cell types (McCabe et al., 2006), but can become toxic if present at high levels due to 
formation of ROS and protein nitrosylation which, amongst other things, also causes 
mitochondrial damage.  
It has been shown that NO can induce both necrotic and apoptotic cell death (Bonfoco et al., 
1995). With respect to ┚-cell destruction, it has been shown that endogenous levels of NO 
are sufficient to induce ┚-cell injury in rodent models of T1DM (Thomas et al., 2002) and 
increased levels of NO caused by cytokine-mediated iNOS induction cause cell death by 
both necrosis (Hoorens et al., 2001, Welsh et al., 1994) and apoptosis (Holohan et al., 2008). 
The relative involvement of NO in the destruction of ┚-cells in human and rodent islets is 
not fully elucidated. Several studies have shown that a combination of IL-1┚ with IFN┛ or 
TNF┙ induces cell death in rodent pancreatic islet cells, predominantly by induction of 
apoptosis but also partly by necrosis (D. Liu et al., 2000, Saldeen, 2000). In rodent ┚-cells the 
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cytokine-induced induction of necrosis seems to be dependent on iNOS-induced production 
of NO as the level of necrotic cell death was greatly reduced in purified ┚-cells from iNOS-
deficient mice (D. Liu et al., 2000). Another study found that inhibition of iNOS in rat islets 
reduced both necrosis and apoptosis induction (Saldeen, 2000). In any case, the cytokine-
induced production of NO seems to play a major role in mediating ┚-cell death in rodent 
experimental models of T1DM. Additionally, we recently demonstrated that a combination 
of IL-1┚ and IFN┛ induces the intrinsic apoptosis pathway in a synergistic manner in a rat 
insulinoma cell line (RIN-r) and showed that iNOS-mediated production of NO was both 
required and sufficient for apoptosis induction (Holohan et al., 2008). This is in agreement 
with previous findings that showed that apoptosis induced by a combination of IL-1┚ and 
IFN┛ is NO-dependent in a rat insulinoma cell line (Storling et al., 2005).  
Human islets have been shown to be less sensitive to NO-induced damage compared to 
rodent cells. As such, inhibition of iNOS could not protect human islets from cytokine-
induced cell death suggesting a NO-independent cytotoxicity. (Delaney et al., 1997, Eizirik 
& Mandrup-Poulsen, 2001, Hoorens et al., 2001). The resistance of human islets towards NO 
compared to rodent islets is speculated to be due to higher levels of heat shock protein 70 
(Hsp70) in human ┚-cells (Burkart et al., 2000) which protects cells from the oxidative stress 
inflicted by NO (Welsh et al., 1994). 
2.3 Role of the Bcl-2 family proteins 
Cytokines can modulate the expression and/or activity of several members of the Bcl-2 
family (Gowda et al., 2008, A. Stephanou et al., 2000, P. Wang et al., 2009, L. Zhang et al., 
2008). The various interactions between the pro- and anti-apoptotic members of this family 
of proteins lie at the heart of the intrinsic pathway of apoptosis (Youle & Strasser, 2008). Bcl-
2 family members are characterised by up to four conserved regions termed Bcl-2 homology 
(BH) domains. The pro-apoptotic multidomain family members Bax and Bak contain three 
BH domains and can be activated to form oligomeric structures in the outer mitochondrial 
membrane that trigger cytochrome c release, which then initiates the intrinsic pathway of 
caspase activation. Activation proceeds through interaction with BH3-only family members 
(harbouring only the third BH domain) that are induced or activated by cellular stress 
signals. Activation of Bax or Bak is counteracted by anti-apoptotic multidomain Bcl-2 family 
members (such as Bcl-2, Bcl-xL, or Mcl-1), which bind and sequester the BH3-only proteins. 
Viral transduction of Bcl-2, the prototype member of the family, was shown to protect 
human islet cells from cytokine-induced apoptosis, giving a first indication that regulation 
of Bcl-2 family proteins by cytokines might contribute to ┚-cell apoptosis (Rabinovitch et al., 
1999). Likewise, adenoviral transduction of Bcl-XL prevented cytokine-mediated apoptosis 
of RIN-r cells (Holohan et al., 2008). 
Several recent studies have addressed the involvement of Bcl-2 family proteins in cytokine-
induced ┚-cell death in more detail. Treatment of human or rat islets with inflammatory 
cytokines resulted in activation of the intrinsic pathway of apoptosis and involved 
activation of the pro-apoptotic BH3-only protein Bad by dephosphorylation (Grunnet et al., 
2009). Dephosphorylation of Bad was also found in a second study analysing cytokine-
treated rat islets, and in addition up-regulation of pro-apoptotic BH3-only proteins Bim and 
Bid was also detected (Mehmeti et al., 2011). In a different study it was shown that in 
primary rat ┚-cells cytokines as well as ER stress lead to increased expression of the pro-
apoptotic BH3-only protein DP5/Hrk in a JNK-dependent manner (Gurzov et al., 2009). Up-
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regulation of DP5 in ┚-cells is mediated by the transcription factor STAT-1 which is 
regulated by IFN┛ (Moore et al., 2011). In addition, inflammatory cytokines led to up-
regulation of the pro-apoptotic BH3-only protein PUMA in primary rat ┚-cells as well as in 
human islets through a pathway involving NF-κB signalling, iNOS activation and ER stress 
(Gurzov et al., 2010). Furthermore, down-regulation of the anti-apoptotic multidomain Bcl-2 
family member Mcl-1 turned out to be critically involved in the cytokine-induced apoptosis 
of the rat insulinoma cell line INS-1E (Allagnat et al., 2011). In summary, exposure to 
cytokines leads to alterations in expression of several Bcl-2 family members in ┚-cells in a 
manner that favours activation of the intrinsic pathway of apoptosis.  
3. く-cell stress in type 1 diabetes 
3.1 Endoplasmic reticulum stress 
It has been suggested that endoplasmic reticulum (ER) stress is involved in ┚-cell 
destruction. Pancreatic -cells are specialised cells that rapidly synthesise and secrete insulin 
in response to fluctuations in blood glucose levels (Pirot et al., 2007). This imparts a heavy 
burden on the ER and, consequently, -cells are particularly susceptible to cellular 
conditions that impair the ER’s ability to correctly fold nascent proteins. Under such 
conditions, the resultant accumulation of unfolded or damaged proteins within the ER 
lumen triggers the unfolded protein response (UPR), an adaptive signalling pathway that 
increases the folding capacity of the ER and restores homeostasis (Szegezdi et al., 2006). 
Although the initial UPR is a protective response, prolonged ER stress can lead to the 
initiation of apoptosis. Thus while under physiological conditions the UPR acts as a pro-
survival mechanism in ┚-cells, chronic ER stress can lead to redirection of the UPR towards 
pro-apoptotic signalling. 
Three ER-localized transmembrane proteins sense the accumulation of unfolded proteins in 
the ER lumen and initiate the UPR, PKR-like ER kinase (PERK), inositol-requiring enzyme 1 
┙ (IRE1) and activating transcription factor 6 (ATF6). These proteins transduce information 
from the ER to the nucleus by activating transcription factors that control genes involved in 
restoring ER function (Szegezdi et al., 2006). The PERK arm of the UPR has been the main 
focus of studies with regard to ┚-cell stress in diabetes, therefore this chapter will focus on 
PERK signalling in more detail. Upon accumulation of unfolded proteins, PERK is activated 
and induces a translational block by phosphorylating eukaryotic initiation factor 2 ┙ (eIF2). 
Phosphorylation of eIF2┙ by PERK leads to inhibition of cap-dependent protein synthesis. 
This reduces the protein load of the ER while allowing cap-independent translation to 
persist and leads to preferential translation of the transcription factor ATF4. One target gene 
induced by ATF4 (in conjunction with ATF6) is C/EBP homologous protein CHOP, a 
transcription factor that is known to promote apoptosis (Zinszner et al., 1998).  
3.1.1 The role of PERK in く-cell function 
The PERK signalling branch of the UPR appears to be essential for the regulation of ┚-cell 
function. Stimulation of insulin production in mouse pancreatic islets leads to 
dephosphorylation of eIF2┙ (P. Zhang et al., 2002) reversing the translational block caused 
by PERK signalling and allowing for increased biosynthesis of insulin. Studies with 
knockout mice showed that PERK is essential for ┚-cell function and survival (Harding et 
al., 2001, P. Zhang et al., 2002). Pancreatic ┚-cells of PERK-/- mice degenerated within the 
first four weeks after birth, and a diabetic phenotype could be observed (Harding et al., 
www.intechopen.com
 
Cytokine-Induced -Cell Stress and Death in Type 1 Diabetes Mellitus 
 
223 
2001, P. Zhang et al., 2002). ┚-cell loss was associated with damaged rough ER and high 
levels of apoptosis in the pancreas (P. Zhang et al., 2002). However, a subsequent study 
discovered that the onset of diabetes in PERK-/- mice is due to developmental defects during 
┚-cell proliferation and differentiation leading to a reduction in ┚-cell mass (W. Zhang et al., 
2006). At the molecular level, down-regulation of PERK in rat ┚-cells was shown to induce 
deregulation of ER chaperones Grp78 and ERp72 and disruption of ER function leading to 
reduced insulin production and reduced cell proliferation (Feng et al., 2009). 
3.1.2 Involvement of the UPR in cytokine-induced く-cell death 
There is some evidence to suggest that cytokines induce ┚-cell apoptosis by stimulating pro-
apoptotic signalling of the UPR. Ca2+ levels in the ER are about four times higher than in the 
cytosol as high Ca2+ levels are required for ER function in aiding protein folding and 
posttranslational processing. Disruption of Ca2+ homeostasis causes severe ER stress 
resulting in accumulation of unfolded proteins in the ER and activation of the UPR. It was 
shown that cytokine-exposure leads to elevated basal cytosolic Ca2+ levels selectively in 
mouse pancreatic ┚-cells compared to glucagon-secreting -cells and this was associated 
with cytokine-induced apoptosis (L. Wang et al., 1999). In line with these results, it was 
shown that increased production of NO in rodent ┚-cells leads to depletion of ER Ca2+ levels 
(Oyadomari et al., 2001). Furthermore, overexpression of the ER-located Ca2+-binding 
protein, calreticulin increased levels of Ca2+ in the ER and made cells more resistant to NO-
induced apoptosis (Oyadomari et al., 2001). This suggests that NO-induced apoptosis in 
rodent ┚-cells is at least partly caused by ER stress induced by NO-mediated Ca2+ depletion.  
Some evidence suggests that NO may regulate Ca2+ levels in ┚-cells through down-
regulation of the sarcoendoplasmic reticulum Ca2+ ATPase 2b (SERCA2b) (Cardozo et al., 
2005). SERCA pumps Ca2+ from the cytoplasm into the ER thus maintaining ER Ca2+ levels. 
Rodent and human islet cells have been reported to express the isoforms SERCA2b and 
SERCA3 (Varadi et al., 1996). Treatment of rodent pancreatic ┚-cells with a combination of 
IL-1┚ and IFN┛ induced transcriptional down-regulation of SERCA2b and this was partially 
prevented by inhibition of iNOS. Furthermore, after inhibition of SERCA, the effect of 
cytokine exposure on ER Ca2+ was abolished (Cardozo et al., 2005). This suggests that NO-
induced depletion of ER Ca2+ is at least in part mediated by SERCA down-regulation. The 
SERCA isoform SERCA2a has been shown to be specifically inactivated by peroxynitrite 
(ONOO-)-mediated nitration of a tyrosine residue within the channel-like domain in vitro 
(Viner et al., 1999). Peroxynitrite is produced in cells by a reaction between NO and the free 
radical superoxide (Pacher et al., 2007). SERCA2a differs from SERCA2b only in regions of 
the C-terminus (Dode et al., 1998) and it could be hypothesised that cytokine-induced NO 
production inhibits SERCA2b Ca2+-ATPase activity by peroxynitrite-mediated nitration in 
the same way. Another possible mechanism by which NO might mediate reduction of ER 
Ca2+ levels is via activation of the ryanodine receptor-2. Ryanodine receptor-2 is a calcium 
channel located in the ER membrane that releases Ca2+ from the ER into the cytosol and has 
been reported to be expressed in mouse pancreatic ┚-cells (Islam et al., 1998). NO-induced 
poly-S-nitrosylation enhances the activity of this calcium channel (Xu et al., 1998) but 
whether this mechanism is relevant to cytokine-exposed ┚-cells remains to be determined. 
Treatment of rodent ┚-cells with a combination of IL-1┚ and IFN┛ induces the expression of 
CHOP in an NO-dependent manner (Fig. 4). This is in line with a number of other reports 
(Cardozo et al., 2001b, Cardozo et al., 2005). Inhibition of iNOS by N5-(1-iminoethyl)-L-
ornithine (L-NIO) or NG-methyl-L-arginine (LMA) blocked cytokine-induced NO 
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production and expression of CHOP. In addition to CHOP, the UPR marker proteins Grp78 
and phosphorylated eIF2 were also found to be up-regulated after cytokine treatment, 
without affecting expression of spliced X-box binding protein 1 (sXBP-1) which is induced 
downstream of IRE1┙ (Fig. 4). Overexpression of iNOS alone was sufficient for CHOP 
expression (Fig. 4) and treatment with the NO-donor molecule S-nitroso-N-acetyl-D,L-
penicillamine (SNAP) induced expression of Grp78 and CHOP (Oyadomari et al., 2001). 
This suggests that NO is sufficient to activate the UPR in rodent pancreatic ┚-cells.  
Pancreatic islet cells from CHOP-/- mice were shown to be resistant to cytokine- and NO-
mediated apoptosis compared to cells from CHOP+/+ and CHOP+/- mice (Oyadomari et al., 
2001). Together these results suggest that the apoptotic effects of cytokine-induced NO are 
mediated by activation of CHOP.  
 
 
Fig. 4. IL-1┚/IFN┛ induced the expression of the pro-apoptotic transcription factor CHOP 
and other UPR markers. (A) A time-course cytokine treatment (IL-1┚ and IFN┛, 60 U/ml of 
each) was carried out and samples assayed for NO production. (B) The same samples were 
then analysed by Western blotting for iNOS and CHOP expression. This data demonstrates 
an increase in NO production, iNOS expression and CHOP induction occurring at 6 h post 
cytokine treatment, although CHOP is not strongly expressed until 9 h. (C) Samples were 
assayed for CHOP expression following cytokine treatment in the presence and absence of 
the iNOS inhibitor L-NIO. Cytokine-induced CHOP expression was decreased in the 
presence of L-NIO indicating that this is an NO-dependent process. (D) Alterations in the 
expression of ER stress-associated proteins after cytokine treatment were analysed by 
Western blotting. The expression of UPR markers Grp78 and phosphorylated eIF2 (p-
eIF2were up in response to cytokine treatment. (E) Production of spliced XBP-1 mRNA 
after cytokine treatment was determined by RT-PCR. Thapsigargin (Tg) treatment was used 
as a positive control. Cytokine treatment did not show an effect on the level of spliced XBP-1 
mRNA. The images presented are representative of three independent experiments. 
Conversely, another study suggested that although cytokine signalling induces ER stress as 
demonstrated by activation of PERK and JNK, induction of CHOP is not required for -cell 
death in rodents (Åkerfeldt et al., 2008). In support of these findings, a recent study suggests 
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that CHOP is not required for ┚-cell death and the development of diabetes in NOD mice 
(Satoh et al., 2011). However, CHOP-/- NOD mice showed delayed production of insulin 
autoimmune antibodies (Satoh et al., 2011) suggesting a role for CHOP in the early onset of 
the autoimmune reaction leading to ┚-cell destruction. Therefore, cytokine-induced ┚-cell 
death may be partly mediated by induction of CHOP. 
While a functional UPR (at least the PERK branch) appears to be essential for ┚-cell function 
and development, its downstream target CHOP has been associated with cytokine-induced 
┚-cell destruction suggesting that PERK signalling regulates ┚-cell function and survival 
under physiological conditions but may switch towards pro-death signalling under 
conditions of cytokine-induced ┚-cell stress.  
3.2 Oxidative stress 
Cytokines induce multiple stress pathways in ┚-cells. Oxidative stress is induced by 
increased production of ROS and an imbalanced, low level of antioxidant enzymes (Sies, 
1997). IL-1┚, TNF┙ and IFN┛ induce the production of ROS and NO by inducing iNOS 
(Rabinovitch & Suarez-Pinzon, 1998). Free oxygen and nitrogen radicals generated can react 
to form peroxynitrite, which is a very strong oxidant. Oxygen free radicals, nitrogen free 
radicals as well as the radical peroxynitrite can react with and damage a range of cellular 
proteins and in this way block metabolic functions and induce ┚-cell death (Azevedo-
Martins et al., 2003). ┚-cells have been shown to be especially susceptible to such oxidative 
stress because they have particularly low levels of antioxidant enzymes (Lenzen et al., 1996, 
Tiedge et al., 1998). 
4. Therapeutic strategies 
The number of people affected by T1DM is approximately 20 million worldwide and is 
rapidly rising (Chabot, 2002). While exogenous administration of insulin is an effective 
treatment for acute hyperglycaemia in T1DM, it does not prevent secondary complications 
(White et al., 2008) and can in some cases lead to hypoglycaemia (Kort et al., 2011). 
Alternative therapeutic strategies include pancreas transplantation and islet transplantation. 
While whole pancreas transplantation is an invasive surgical method associated with major 
complications, islet transplantation is less invasive and associated with significantly lower 
morbidity and mortality. Successful islet transplantation would result in insulin 
independence, protection from hypoglycaemia, improvement of microvascular 
complications, improved patient survival and enhanced quality of life (Kort et al., 2011). The 
method is currently in clinical trials and has been used to treat around 1,000 individuals 
worldwide (Kort et al., 2011). Islet transplantation has many limitations, including limited 
availability of suitable islet graft donors, high cost and high rate of partial or total graft 
failure. Islet graft failure can be caused by allorejection, toxicity of immunosuppressive 
drugs that are required to reduce immune rejection, glucotoxicity, and recurrence of 
autoimmunity (Kort et al., 2011).  
An approach to reduce ┚-cell death in islet grafts is the transfer of therapeutically useful 
genes into islet cells prior to transplantation (McCabe et al., 2006). The development of gene 
therapy techniques that can protect ┚-cells from autoimmune destruction may not only 
improve outcomes after islet transplantation but may also lead to preventive therapies for 
patients at high risk of developing T1DM (McCabe et al., 2006).  
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Various candidate transgenes are being examined for their potential in protecting ┚-cells 
under various stresses including cytokine-exposure and oxidative stress. The rational choice 
of therapeutic genes is helped by understanding the mechanism of -cell destruction which 
has been the subject of this chapter. Potential targets will be reviewed in this section. Target 
genes studied to date encode regulators of the cytokine signal transduction pathways, 
molecules that inhibit -cell apoptosis, antioxidant enzymes, immunoregulatory proteins 
and pro-survival cytokines (McCabe et al., 2006). 
4.1 Anti-apoptotic gene transfer 
Apoptosis plays a major role in ┚-cell death in T1DM (see section 2.). The transfer of anti-
apoptotic genes as a strategy to counteract islet destruction has been explored. Candidate 
genes include those expressing cytoprotective and anti-apoptotic heat shock proteins (Hsps) 
and anti-apoptotic Bcl-2 family proteins. Hsp70 is one of the major heat shock proteins in 
mammals and is thought to be responsible for the relative resistance of human ┚-cells to 
cytokine-induced stress and death (Burkart et al., 2000). Hsp70 can protect cells under 
conditions of stress by directly inhibiting the transduction of the apoptotic signal, by 
decreasing the amount of oxidative stress and also by reducing ER stress via its chaperone 
activity. It has been shown that pre-conditioning by heat shock could protect pancreatic islet 
cells from insults by NO, ROS and the cytotoxic drug streptozocin and this increased 
resistance correlated with induced expression of Hsp70 (Bellmann et al., 1995). Another Hsp 
that is potentially capable of protecting ┚-cells is heme oxygenase (HO-1), also known as 
Hsp32. HO-1 exerts its cytoprotective effects mainly by reduction of oxidative stress 
(McCabe et al., 2006) and overexpression of HO-1 could protect cytokine-exposed islet cells 
from apoptosis (Pileggi et al., 2001, Ye & Laychock, 1998). Bcl-2 family proteins, such as the 
anti-apoptotic Bcl-2, are major regulators of the apoptotic signalling cascade. It has been 
suggested that an impaired induction of anti-apoptotic Bcl-2 plays a role in cytokine-
induced dysfunction and cell death of human islet cells relative to porcine islets (Piro et al., 
2001). Moreover, overexpression of Bcl-2 was shown to protect ┚-cells from cytokine-
induced apoptosis (Y. Liu et al., 1996) and increase the longevity of islet grafts after 
transplantation (Contreras et al., 2001). Several mechanisms by which Bcl-2 might exert ┚-
cell protection have been suggested (McCabe et al., 2006). These include inhibition of 
cytochrome c release from mitochondria, inhibition of ER stress-induced apoptosis and 
blocking of Ca2+ release from the ER. It was shown that Bcl-2 overexpression can reduce ER 
stress-induced apoptosis in islet cells (Contreras et al., 2003). Both of these mechanisms have 
been associated with cytokine-induced ┚-cell death. Another candidate transgene may be 
the gene encoding the cellular FADD-like IL-1┚-converting enzyme (FLICE)-like inhibitory 
protein (cFlip) as its overexpression has been shown to inhibit the activation of caspase-8 in 
┚-cells exposed to TNF┙ (Cottet et al., 2002).  
4.2 Anti-cytokine gene transfer 
Inhibition of NF-κB, a main effector of cytokine-signalling, was shown to reduce cytokine-
induced apoptosis in rodent ┚-cells in vitro (Baker et al., 2001, Heimberg et al., 2001) and in 
vivo (Eldor et al., 2006) and Fas-induced apoptosis in human islet cells (Giannoukakis et al., 
2000). It should be noted that active NF-κB has been shown to be an essential factor in 
mediating glucose-stimulated insulin secretion (Norlin et al., 2005) and while NF-κB 
inhibition may protect ┚-cells from apoptosis it may also interfere with insulin secretion. 
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JNK is another candidate target for anti-cytokine gene therapy. Inhibition of JNK has been 
shown to protect pig islet cells from apoptosis and loss of JNK function after isolation and also 
after transplantation suppresses IL-1┚ induced apoptosis in insulin-secreting rodent cell lines 
(Nikulina et al., 2003, Noguchi et al., 2005). Other potential transgenes interfering with 
cytokine signalling include feedback inhibitors, e.g. SOCS (Yasukawa et al., 2000). It is thought 
that a compromised ability to up-regulate SOCS in response to cytokine exposure makes ┚-
cells particularly susceptible to cytokine-induced damage (Karlsen et al., 2001, Yasukawa et al., 
2000). The overexpression of SOCS-3 in response to IL-1┚ was shown to be slower in ┚-cells 
compared to other cell lines (Karlsen et al., 2001). It was also demonstrated that SOCS-3 
overexpression can protect rodent ┚-cells from cytokine-induced death (Karlsen et al., 2001).   
4.3 Anti-oxidant gene transfer 
The protective effects of several antioxidant enzymes including catalase, glutathione 
peroxidase and the superoxide dismutases (SODs) MnSOD and CuZnSOD have been 
investigated. While results have not been entirely consistent, many studies have 
demonstrated that activation or overexpression of these enzymes can protect ┚-cells against 
oxidative stress or cytokine-induced destruction at least to some extent (Benhamou et al., 
1998, Bertera et al., 2003, Hohmeier et al., 1998, Lortz & Tiedge, 2003, Lortz et al., 2000). 
These studies have shown that antioxidant gene transfer is a promising strategy in 
prolonging islet graft longevity. However, it has also been observed that transfer of 
antioxidant genes alone could not protect ┚-cells long term against toxicity caused by 
cytokine exposure and oxidative stress. 
5. Conclusion 
In recent years basic biomedical research has delivered a wealth of knowledge about the 
pathways by which inflammatory cytokines sensitise ┚-cells to cell death during the course 
of T1DM pathogenesis. Although the picture is still incomplete, we have learned about the 
major stresses to which ┚-cells are exposed. Some of the molecular players mediating these 
stresses have been identified. In particular, pro-inflammatory cytokines IL-1┚, TNF┙ and 
IFN┛ have been implicated as main mediators of ┚-cell stress and death during T1DM. It 
emerges that these cytokines synergistically activate transcriptional programs that lead to 
NO signalling, oxidative stress, ER stress, as well as modulation of Bcl-2 family protein 
expression. How these pathways precisely intersect has not yet been fully clarified. Studies 
elucidating these mechanisms may provide the knowledge to improve therapy. Islet 
transplantation, a therapeutic approach that would overcome the need of continuous insulin 
administration, is still in its infancy. Modern gene transfer techniques offer a huge potential 
for improvement to islet transplantation as it can help overcoming the cellular and 
autoimmune-mediated stress transplanted islets are exposed to. The experiments mentioned 
at the end of this chapter are encouraging that the accumulating knowledge of the molecules 
and pathways mediating ┚-cell stress will help to develop gene therapeutic approaches 
alleviating these stresses, thus improving survival of transplanted islets. 
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